Cargando…

Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist

A ligand-based virtual screening exercise examining likely bioactive conformations of AM 580 (2) and AGN 193836 (3) was used to identify the novel, less lipophilic RARα agonist 4-(3,5-dichloro-4-ethoxybenzamido)benzoic acid 5, which has good selectivity over the RARβ, and RARγ receptors. Analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clarke, Earl, Jarvis, Christopher I., Goncalves, Maria B., Kalindjian, S. Barret, Adams, David R., Brown, Jane T., Shiers, Jason J., Taddei, David M.A., Ravier, Elodie, Barlow, Stephanie, Miller, Iain, Smith, Vanessa, Borthwick, Alan D., Corcoran, Jonathan P.T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823845/ https://www.ncbi.nlm.nih.gov/pubmed/29288071 http://dx.doi.org/10.1016/j.bmc.2017.12.015

Ejemplares similares

Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury
por: Goncalves, Maria B., et al.
Publicado: (2019)

Corrigendum to “Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury” [Bioorg. Med. Chem. Lett. 29(8) (2019) 995–1000]
por: Goncalves, Maria B., et al.
Publicado: (2019)

Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review
por: Borthwick, Alan D., et al.
Publicado: (2020)

Retinoic acid receptor-α signalling antagonizes both intracellular and extracellular amyloid-β production and prevents neuronal cell death caused by amyloid-β
por: Jarvis, C I, et al.
Publicado: (2010)

Amyloid β inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist
por: Goncalves, Maria B, et al.
Publicado: (2013)

Regulation of Myelination by Exosome Associated Retinoic Acid Release from NG2-Positive Cells
por: Goncalves, Maria B., et al.
Publicado: (2019)

Retinoic acid synthesis by NG2 expressing cells promotes a permissive environment for axonal outgrowth
por: Goncalves, Maria B., et al.
Publicado: (2018)

Potent Inhibition of Heterotopic Ossification by Nuclear Retinoic Acid Receptor γ Agonists
por: Shimono, Kengo, et al.
Publicado: (2011)

A retinoic acid receptor β agonist (CD2019) overcomes inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord
por: Agudo, Marta, et al.
Publicado: (2010)

Novel Retinoic Acid Receptor Alpha Agonists for Treatment of Kidney Disease
por: Zhong, Yifei, et al.
Publicado: (2011)

Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist
por: Zhao, Jian, et al.
Publicado: (2022)

In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer
por: Saidi, Samir A, et al.
Publicado: (2006)

RARβ Agonist Drug (C286) Demonstrates Efficacy in a Pre-clinical Neuropathic Pain Model Restoring Multiple Pathways via DNA Repair Mechanisms
por: Goncalves, Maria B., et al.
Publicado: (2019)

Antiepileptogenic Effect of Retinoic Acid
por: Rosiles-Abonce, Artemio, et al.
Publicado: (2021)

In silico discovery of novel Retinoic Acid Receptor agonist structures
por: Schapira, Matthieu, et al.
Publicado: (2001)

Design, Synthesis and Evaluation of Indene Derivatives as Retinoic Acid Receptor α Agonists
por: Guan, Xianghong, et al.
Publicado: (2016)

Effect of Specific Retinoic Acid Receptor Agonists on Noise-Induced Hearing Loss
por: Kwak, Sang Hyun, et al.
Publicado: (2019)

Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat
por: Ponthan, F, et al.
Publicado: (2001)

Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells
por: Hammond, L A, et al.
Publicado: (2001)

Disruption of Retinoic Acid Receptor Alpha Reveals the Growth Promoter Face of Retinoic Acid
por: Somenzi, Giulia, et al.
Publicado: (2007)

Synthesis of A-9758, an Inverse Agonist of Retinoic Acid-Related Orphan Receptor γt
por: Marvin, Christopher C., et al.
Publicado: (2022)

Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells
por: Bilip, Maja, et al.
Publicado: (2020)

Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer
por: Shukla, Nikunj M., et al.
Publicado: (2012)

The OECD Program to Validate the Rat Hershberger Bioassay to Screen Compounds for in Vivo Androgen and Antiandrogen Responses. Phase 1: Use of a Potent Agonist and a Potent Antagonist to Test the Standardized Protocol
por: Owens, William, et al.
Publicado: (2006)

The regulation of mitochondrial dynamics in neurite outgrowth by retinoic acid receptor β signaling
por: Trigo, Diogo, et al.
Publicado: (2019)

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
por: Kevin, Richard C., et al.
Publicado: (2019)

Discovery of Highly Potent Liver X Receptor β Agonists
por: Kick, Ellen K., et al.
Publicado: (2016)

The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells
por: Ibabao, Christopher N., et al.
Publicado: (2015)

Attenuation of Hypertrophy in Human MSCs via Treatment with a Retinoic Acid Receptor Inverse Agonist
por: Riedl, Moritz, et al.
Publicado: (2020)

UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
por: Zhang, Weihe, et al.
Publicado: (2014)

Potent and Orally Bioavailable Antiplatelet Agent, PLD-301, with the Potential of Overcoming Clopidogrel Resistance
por: Chen, Jingyu, et al.
Publicado: (2016)

Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors
por: Feng, Yangbo, et al.
Publicado: (2020)

D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II
por: Gori, Sadakatali S., et al.
Publicado: (2022)

A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein
por: Watanabe, Hiroshi, et al.
Publicado: (2020)

Unanticipated Characteristics of a Selective, Potent Neuromedin-U Receptor 2 Agonist
por: Mehrotra, Suneet, et al.
Publicado: (2022)

Hepatic retinoic acid receptor alpha mediates all‐trans retinoic acid's effect on diet‐induced hepatosteatosis
por: Cassim Bawa, Fathima N., et al.
Publicado: (2022)

Generation of Retinaldehyde for Retinoic Acid Biosynthesis
por: Belyaeva, Olga V., et al.
Publicado: (2019)

Structure-based discovery of potent and selective melatonin receptor agonists
por: Patel, Nilkanth, et al.
Publicado: (2020)

Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists
por: Szűcs, Edina, et al.
Publicado: (2020)

Lithocholic Acid Amides as Potent Vitamin D Receptor Agonists
por: Yoshihara, Ayana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1mb1d15nc07adjnv08domo9lia